Iran’s Leap into the Future; an Exploration of Tissue Engineering Companies: Review Article

  • Narges Fereydouni Department of Tissue Engineering, School of Medicine, Fasa University of Medical Sciences, Fasa, Iran
  • Mohammad Ebrahim Astaneh Department of Tissue Engineering, School of Medicine, Fasa University of Medical Sciences, Fasa, Iran
  • Morteza Seifalah-Zade Department of Tissue Engineering, School of Medicine, Fasa University of Medical Sciences, Fasa, Iran
  • Alireza Hashemzadeh Department of Clinical Biochemistry, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran
Keywords: Tissue engineering; Commercial; Service; Research; Company

Abstract

Background: This review represents the first comprehensive compilation of data on Iranian commercial, service, and research entities in the field of tissue engineering up to 2024.

Methods: Through an extensive search of official websites, 56 companies were identified: 29 commercial enterprises, 17 service providers, and 10 research institutions. The majority (64%) of these companies are headquartered in Tehran, with many established post-2004.

Results: Biomaterials account for half of the product portfolio, with 38% of ongoing research focused on this area. Although cell-based products currently make up only 12% of offerings, they are the subject of 38% of current research, indicating significant potential for future growth.

Conclusion: This study provides a detailed overview of the development and future prospects of Iran's tissue engineering sector. The key conclusion emphasizes the need for an expanded focus on cell-based therapies and the establishment of stronger regulatory frameworks to facilitate the commercialization of innovative products. The review identifies key research gaps and proposes directions for future study, utilizing a descriptive methodology with in-depth data analysis and theoretical discussion.

 

Published
2025-02-23
Section
Articles